Open AccessBook
Myasthenia Gravis
Huub Oosterhuis
- 01 Jan 1997
2.4K
About: The article was published on 01 Jan 1997. and is currently open access. The article focuses on the topics: Myasthenia gravis & Ocular myasthenia.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab
TL;DR: The effect of tocilizumab, a blocker of interleukin-6 signalling, is described in two female myasthenia patients with high titres of serum acetylcholine receptor antibodies and insufficient response to rituximab.
70
The cholinergic anti-inflammatory pathway: An innovative treatment strategy for neurological diseases.
Bin Han,Xiuping Li,Junwei Hao +2 more
TL;DR: This review focuses on the anti‐inflammatory benefits of non‐neuronal and neuronal ACh as a means of providing new insights into treating inflammation‐related neurological diseases, as exemplified by those described herein.
70
Serum cytokine and chemokine profiles in patients with myasthenia gravis
TL;DR: Some cytokines, such as IL‐4, IL‐15, and VEGF, may play roles in the pathogenesis of MG, and correlations between clinical parameters and cytokine/chemokine levels in patients with MG were examined.
70
The auto-antigen repertoire in myasthenia gravis
Kathleen Vrolix,Judith Fraussen,Peter C. M. Molenaar,Mario Losen,Veerle Somers,Piet Stinissen,Marc H. De Baets,Pilar Martinez-Martinez +7 more
TL;DR: The reported auto-antibodies in MG patients are comprehensively reviewed and their role in the pathology of this autoimmune disease is discussed.
70
CDR3 spectratyping analysis of the TCR repertoire in myasthenia gravis.
Yoh Matsumoto,Hidenori Matsuo,Hiroshi Sakuma,Il-Kwon Park,Yukiko Tsukada,Kuniko Kohyama,Takayuki Kondo,Satoshi Kotorii,Noritoshi Shibuya +8 more
TL;DR: Large-scale cross-sectional and longitudinal TCR studies by CDR3 spectratyping using PBL and thymus tissues from MG patients suggest that persistent clonal expansions of T cells in MG patients are associated with the development and maintenance of MG.
70